{
    "organizations": [],
    "uuid": "bf1ef26fde49840a0ca96faa1cf7b6084d237d3c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-summit-expands-enrolment-in-phaseo/brief-summit-expands-enrolment-in-phaseout-dmd-phase-2-clinical-trial-to-include-planned-additional-group-idUSASB0C95Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Summit Expands Enrolment In Phaseout DMD Phase 2 Clinical Trial To Include Planned Additional Group",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Summit Therapeutics Plc:\n* SUMMIT EXPANDS ENROLMENT IN PHASEOUT DMD PHASE 2 CLINICAL TRIAL TO INCLUDE PLANNED ADDITIONAL GROUP Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T20:20:00.000+02:00",
    "crawled": "2018-03-08T17:03:26.041+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "summit",
        "therapeutic",
        "plc",
        "summit",
        "expands",
        "enrolment",
        "phaseout",
        "dmd",
        "phase",
        "clinical",
        "trial",
        "include",
        "planned",
        "additional",
        "group",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}